Ong, M., Kolinsky, M. P., Chi, K. N., Hotte, S. J., Brundage, M. D., Khalaf, D. J., Boren, D., Reaume, M. N., Wyatt, A. W., Parulekar, W. R., Ding, K., Jafri, M. (2026). A randomized phase III trial investigating platinum and taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) patients with alterations in DNA damage response (DDR) genes (OPTION-DDR) CCTG-PR-25 NCT06439225.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5143